Page 16 - Read Online

Page 8 of 8 Kyriazis. J Transl Genet Genom 2018;2:7. I https://doi.org/10.20517/jtgg.2018.04

36. Joyner MJ. Precision medicine, cardiovascular disease and hunting elephants. Prog Cardiovasc Dis 2016;58:651-60.
37. MacRae CA, Vasan RS. Closing the phenotype gap in precision medicine. Circulation 2016;133:2634-9.
38. Bausch KC. The Theory and Practice of Third Phase Science. In: Metcalf G, editor. Social Systems and Design. Springer, Tokyo:
Translational Systems Sciences; 2014.
39. Olshansky SJ. Is life extension today a faustian bargain? Front Med (Lausanne) 2017;4:215.
40. Barat Ι, Andreasen F, Damsgaard EMS. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol
2001;51:615-22.
41. Tang HY, Sayers SL, Weissinger G, Riegel B. The role of depression in medication adherence among heart failure patients. Clin Nurs Res
2014;23:231-44.
42. Donadiki EM, Jiménez-García R, Hernández-Barrera V. Health belief model applied to non-compliance with HPV vaccine among female
university students. Public Health 2014;128:268-73.
43. Ehrlich S, Newkirk T, Pallas S, Riedinger T, Jackson D. Why are patients with chronic disease nonadherent with their prescription
medications? Proceeding of American Academy of Physician Assistants 2017 conference; 2017 May 15-19; Las Vegas, USA.
44. Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei GC, Casati M, Franchi C, Djade CD, Nobili A. Medication
non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging 2014;31:283-9.
45. Mukhtar O, Weinman J, Jackson SH. Intentional non-adherence to medications by older adults. Drugs Aging 2014;31:149-57.
46. Shepherd JG, Locke E, Zhang Q. Health services use and prescription access among uninsured patients managing chronic diseases. J
Community Health 2014;39:572-83.
47. Domingue BW, Belsky DW. The social genome: current findings and implications for the study of human genetics. PLoS Genet
2017;13:e1006615.
48. Cole SW. Human social genomics. PLoS Genet 2014;10:e1004601.
49. Portin P. A comparison of biological and cultural evolution. J Genet 2015;94:155-68.
50. Creanza N, Kolodny O, Feldman MW. Cultural evolutionary theory: how culture evolves and why it matters. Proc Natl Acad Sci U S A
2017; doi: 10.1073/pnas.1620732114.
51. Zierer J, Menni C, Kastenmüller G, Spector TD. Integration of ‘omics’ data in aging research: from biomarkers to systems biology. Aging
Cell 2015;14:933-44.
52. Kyriazis M. Technological integration and hyper-connectivity: tools for promoting extreme human lifespans. Complexity 2014;20:15-24.
53. Kyriazis M. Reductionism versus Systems Thinking in Aging Research. In: Ahmad S. editor, Aging: Exploring a complex phenomenon.
Boca Raton: CRC Press; 2018.
54. Ogino S, Lochhead P, Chan AT. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment,
host, and disease. Mod Pathol 2013;26:465-84.
55. Ogino S, Fuchs CS, Giovannucci E. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.
Expert review of molecular diagnostics 2012;12:621-8.
56. Schully SD, Khoury MJ. What is translational genomics? An expanded research agenda for improving individual and population health.
Appl Transl Genom 2014;3:82-3.
57. Heneghan C, Ben Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials 2017;18:122.
58. Abernethy AP, Wheeler JL. True translational research: bridging the three phases of translation through data and behavior. Translational
Behav Med 2011;1:26-30.
59. London AJ, Kimmelman J. Why clinical translation cannot succeed without failure. eLife 2015;4:e12844.
60. Marusic U, Grosprêtre S. Non-physical approaches to counteract age-related functional deterioration: applications for rehabilitation and
neural mechanisms. Eur J Sport Sci 2018;20:1-11.
61. Amendola LM, Robinson JO, Hart R, Biswas S, Lee K, Bernhardt BA, East K, Gilmore MJ, Kauffman TL, Lewis KL, Roche M, Scollon
S, Wynn J, Blout C. Why patients decline genomic sequencing studies: experiences from the CSER consortium. J Genet Couns 2018; doi:
10.1007/s10897-018-0243-7.
62. Wolf SM, Burke W, Koenig BA. Mapping the ethics of translational genomics: situating return of results and navigating the research-clinical
divide. J Law Med Ethics 2015;43:486-501.